Low Density Lipoprotein from Human Plasma

• Description:

  Low Density Lipoprotein from Human Plasma_x000D_ Catalog number: B2010215_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Volume/Weight: 50 mg_x000D_ pH: na_x000D_ Supplied as: Ready-to-use_x000D_ Appearance: Solution_x000D_ Applications: human plasma derived Low-density lipoprotein (LDL), a lipoprotein that carries cholesterol._x000D_ Storage: -20C_x000D_ Keywords: Low-density lipoprotein, LDL, beta-lipoprotein, cholesterol oxidized LDL, cholesterol low-density lipoprotein, cholesterin._x000D_ Grade: Biotechnology grade. All components are highly pure (minimum 99%). All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered on a 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Hartley A, Haskard D, Khamis R. Oxidized LDL and anti-oxidized LDL antibodies_x000D_ in atherosclerosis - Novel insights and future directions in diagnosis and_x000D_ therapy. Trends Cardiovasc Med. 2019 Jan;29(1):22-26._x000D_ _x000D_ 2: Motamed M, Nargesi AA, Heidari B, Mirmiranpour H, Esteghamati A, Nakhjavani_x000D_ M. Oxidized Low-Density Lipoprotein (ox-LDL) to LDL Ratio (ox-LDL/LDL) and ox-_x000D_ LDL to High-Density Lipoprotein Ratio (ox-LDL/HDL). Clin Lab. 2016 Sep_x000D_ 1;62(9):1609-1617._x000D_ _x000D_ 3: Song Y, Hou M, Li Z, Luo C, Ou JS, Yu H, Yan J, Lu L. TLR4/NF-κB/Ceramide_x000D_ signaling contributes to Ox-LDL-induced calcification of human vascular smooth_x000D_ muscle cells. Eur J Pharmacol. 2017 Jan 5;794:45-51._x000D_ _x000D_ 4: Wang M, Wu Y, Yu Y, Fu Y, Yan H, Wang X, Li T, Peng W, Luo D. Rutaecarpine_x000D_ prevented ox-LDL-induced VSMCs dysfunction through inhibiting overexpression of_x000D_ connexin 43. Eur J Pharmacol. 2019 Jun 15;853:84-92._x000D_ _x000D_ 5: Fu C, Yin D, Nie H, Sun D. Notoginsenoside R1 Protects HUVEC Against Oxidized_x000D_ Low Density Lipoprotein (Ox-LDL)-Induced Atherogenic Response via Down-_x000D_ Regulating miR-132. Cell Physiol Biochem. 2018;51(4):1739-1750._x000D_ _x000D_ 6: Yin R, Zhu X, Wang J, Yang S, Ma A, Xiao Q, Song J, Pan X. MicroRNA-155_x000D_ promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2_x000D_ pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice. Ann_x000D_ Palliat Med. 2019 Nov;8(5):676-689._x000D_ _x000D_ 7: Chang W, Zhu F, Zheng H, Zhou Z, Miao P, Zhao L, Mao Z. Glucagon-like_x000D_ peptide-1 receptor agonist dulaglutide prevents ox-LDL-induced adhesion of_x000D_ monocytes to human endothelial cells: An implication in the treatment of_x000D_ atherosclerosis. Mol Immunol. 2019 Dec;116:73-79._x000D_ _x000D_ 8: Akhi R, Wang C, Kyrklund M, Kummu O, Turunen SP, Hyvärinen K, Kullaa A, Salo_x000D_ T, Pussinen PJ, Hörkkö S. Cross-reactive saliva IgA antibodies to oxidized LDL_x000D_ and periodontal pathogens in humans. J Clin Periodontol. 2017 Jul;44(7):682-691._x000D_ _x000D_ 9: Yin J, Hou X, Yang S. microRNA-338-3p promotes ox-LDL-induced endothelial_x000D_ cell injury through targeting BAMBI and activating TGF-β/Smad pathway. J Cell_x000D_ Physiol. 2019 Jul;234(7):11577-11586._x000D_ _x000D_ Products Related to Low Density Lipoprotein from Human Plasma: Serum and Plasma

• Short Description:

  Catalog Number: B2010215 (50 mg)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5